This post was originally published on this site

UK shares have fared surprisingly well since the stock market crash in March. Some better than others, of course. Sectors like pharmaceuticals, technology, and gaming have thrived. Two such fortunate companies are Omega Diagnostics Group (LSE:ODX) and Frontier Developments (LSE:FDEV). Considering their rapid share price rise, you might be tempted to buy these UK shares in another stock market crash. But would that be a wise move?

© Provided by The Motley Fool Graph Falling Down in Front Of United Kingdom Flag

Omega Diagnostics share price slips

Earlier this week, the UK government ordered 1m antibody tests from the UK rapid test consortium. Scottish medical diagnostics company Omega is a member of the consortium and will manufacture around 175,000 of this order. Besides the initial 175k tests, the company will manufacture at least 25% of demand for any further orders placed. News of the order lifted the Omega share price on Wednesday. However, it seems a lot of positive sentiment has already been priced into the stock as its share price slipped back today.

Load Error

Omega’s price-to-earnings ratio (P/E) has skyrocketed in recent months and is now a hefty 126. This is even higher than FTSE 100 pharma favourite AstraZeneca. This shows that investors have a lot of confidence in the firm. But it’s highly speculative, and it could be some time before substantial profits arise. Earnings per share are less than 1p, and Omega doesn’t offer a dividend.

© Provided by The Motley Fool Arrow descending on a graph portraying stock market crash

Profit predictions difficult

The purpose of the home-test is to check individuals for Covid-19 antibodies. This will help support nationwide studies into how widespread the disease is. By early next month, Omega intends to produce up to 200k tests a week.

However, ongoing demand for the Covid-19 tests is yet unclear, which makes profit predictions difficult. In theory, Omega could produce around 3.8m lateral flow tests at full capacity during FY 2021. This would generate revenues of up to £5.7m (according to Finncap research).

Besides five different Covid-19 tests, the company specialises in allergies, food intolerance, and HIV testing equipment. Each offers scope for growth and income, but I’m not convinced it’s at a level that warrants the current share price. Considering the company has a market capitalisation of £181m, I think it’s probably overvalued.

Despite this being a hot share and one you may be tempted to buy in a stock market crash, I think the Omega share price would have to fall a long way before it would be worth buying.

A hotter UK share I’d buy in a market crash

A second UK share you might be tempted to buy in a stock market crash is Frontier Developments. The computer games developer and publisher has enjoyed an exceptional year and looks to have a profitable future too. Last month it confirmed revenue and profit slightly ahead of expectations for the year ending 31 May, leading analysts to raise their share price target.

Frontier Developments manufactures popular games including Planet Zoo (launched 2019), Jurassic World Evolution, Elite Dangerous and Planet Coaster. 2021 revenues are expected to be between £90m and £95m. Frontier has a P/E of 60 and earnings per share are 41p. It doesn’t offer a dividend.

Frontier looks to me like it knows what its consumers are looking for and how to give it to them. With the gaming sector thriving, I’d consider buying Frontier Development shares during a stock market crash.

Are you looking for small-cap growth prospects to boost your earning potential? Experts like The Motley Fool (and their exclusive reports) are here to boost your chances of making a million, through investing. Let them help you…

The high-calibre small-cap stock flying under the City’s radar

Adventurous investors like you won’t want to miss out on what could be a truly astonishing opportunity…

You see, over the past three years, this AIM-listed company has been quietly powering ahead… rewarding its shareholders with generous share price growth thanks to a carefully orchestrated ‘buy and build’ strategy.

And with a first-class management team at the helm, a proven, well-executed business model, plus market-leading positions in high-margin, niche products… our analysts believe there’s still plenty more potential growth in the pipeline.

Here’s your chance to discover exactly what has got our Motley Fool UK investment team all hot-under-the-collar about this tiny £350+ million enterprise… inside a specially prepared free investment report.

But here’s the really exciting part… right now, we believe many UK investors have quite simply never heard of this company before!

Click here to claim your copy of this special investment report — and we’ll tell you the name of this Top Small-Cap Stock… free of charge!

More reading

Kirsteen has no position in any of the shares mentioned. The Motley Fool UK has recommended Frontier Developments. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

The post 2 UK shares you may be tempted to buy in a stock market crash appeared first on The Motley Fool UK.

Continue Reading